Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acid Therapeutics|November 14, 2019
Endocytosis Controls siRNA Efficiency: Implications for siRNA Delivery Vehicle Design and Cell-Specific TargetingDaniel Vocelle, Christina Chan, S Patrick Walton
Pharmaceuticals (Basel, Switzerland)|August 27, 2013
Design of siRNA Therapeutics from the Molecular ScalePhillip Angart, Daniel Vocelle, Christina Chan, et al.
Microscopy (Oxford, England)|June 12, 2020
Kinetic analysis of the intracellular processing of siRNAs by confocal microscopyDaniel Vocelle, Olivia M Chesniak, Milton R Smith, et al.
The Journal of Nutritional Biochemistry|January 13, 2025
The supply of branched-chain amino acids and branched-chain keto acids alter lipid metabolism, oxidative stress, and apoptosis in primary bovine hepatocytesJayasimha R Daddam, Mounica Sura, Daniel Vocelle, et al.
Metabolic Engineering|July 27, 2025
Engineering quorum-sensing circuits in Synechococcus elongatus PCC 7942 towards self-inducible systemsEmmanuel J Kokarakis, María Santos-Merino, Sajjad Ghaffarinasab, et al.
Technology|October 25, 2016
Dextran functionalization enhances nanoparticle-mediated siRNA delivery and silencingDaniel Vocelle, Olivia M Chesniak, Amanda P Malefyt, et al.
Vaccines|March 30, 2023
Phosphatidylserine-Exposing Annexin A1-Positive Extracellular Vesicles: Potential Cancer BiomarkersGloria I Perez, Matthew P Bernard, Daniel Vocelle, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
The membrane-associated ubiquitin ligase MARCHF8 promotes cancer immune evasion by degrading MHC class I proteinsMohamed I Khalil, Jie Wang, Canchai Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2026
The membrane-associated ubiquitin ligase MARCHF8 degrades MHC-I in HPV-positive head and neck cancer for immune evasionMohamed I Khalil, Jie Wang, Lexi Vu, et al.
Pageof 2